CGC vs OGI

For growth investors, Organigram Global Inc.

(OGI) is the stronger pick with 16. 4% revenue growth year-over-year, versus -9. 5% for Canopy Growth Corporation (CGC). Analysts rate Organigram Global Inc. (OGI) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Organigram Global Inc.

(OGI) delivered a total return of -86. 5%, compared to -99. 5% for Canopy Growth Corporation (CGC). Over 10 years, the gap is even starker: CGC returned -94. 4% versus OGI's -95. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Organigram Global Inc.

(OGI) is the lower-risk stock at 1. 30β versus Canopy Growth Corporation's 1. 95β — meaning CGC is approximately 50% more volatile than OGI relative to the S&P 500. On balance sheet safety, Organigram Global Inc. (OGI) carries a lower debt/equity ratio of 3% versus 72% for Canopy Growth Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Organigram Global Inc.

(OGI) is pulling ahead at 16. 4% versus -9. 5% for Canopy Growth Corporation (CGC). On earnings-per-share growth, the picture is similar: Organigram Global Inc. grew EPS 70. 8% year-over-year, compared to 37. 1% for Canopy Growth Corporation. Over a 3-year CAGR, OGI leads at 8. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Organigram Global Inc.

(OGI) is the more profitable company, earning -9. 6% net margin versus -222. 4% for Canopy Growth Corporation — meaning it keeps -9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OGI leads at -34. 1% versus -43. 5% for CGC. At the gross margin level — before operating expenses — CGC leads at 29. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Organigram Global Inc.

(OGI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Canopy Growth Corporation (CGC) carries a higher beta of 1. 95 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (OGI: -95. 6%, CGC: -94. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CGC is a small-cap quality compounder stock; OGI is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.